Breast DiseasesFibrocystic Breast DiseaseSurvivorsBreastBreast NeoplasmsFibroadenomaAdenofibromaCarcinoma, Ductal, BreastMammographyCarcinoma, Intraductal, NoninfiltratingHyperplasiaBreast CystNipplesMenopauseCarcinoma in SituPrecancerous ConditionsRisk FactorsCase-Control StudiesCarcinoma, LobularBiopsyBiopsy, NeedleReceptors, EstrogenUltrasonography, MammaryBreast FeedingMastectomyPalpationMastitisReceptors, ProgesteroneAge FactorsTumor Markers, BiologicalNeoplasm InvasivenessProspective StudiesRiskPrognosisCohort StudiesFollow-Up StudiesPostmenopauseTime FactorsEstrogensBreast Neoplasms, MaleParityCarcinomaMenstruationPremenopauseBody FluidsQuestionnairesNeoplasmsMenarcheRisk AssessmentImmunohistochemistryIncidenceOdds RatioNeoplasm MetastasisProportional Hazards ModelsRetrospective StudiesEstrogen Replacement TherapyCell Line, TumorNeoplasm StagingReceptor, erbB-2Breast ImplantsCathepsin DLymphatic MetastasisSensitivity and SpecificityConfidence IntervalsMass ScreeningBreast Self-ExaminationTamoxifenNeoplasm ProteinsUnited StatesProgestinsOutpatient Clinics, HospitalQuality of LifeDisease ProgressionMultivariate AnalysisFamily HealthLogistic ModelsGene Expression Regulation, Neoplastic